Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blann

Showing results (411-420 of 420) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 420 results.
Dalton Transactions (Cambridge, England : 2003)|March 10, 2021
Ethylene oligomerisation chromium catalysts with unsymmetrical PCNP ligandsKevin Blann, Annette Bollmann, Gavin M Brown, et al.
British Journal of Cancer|May 19, 2011
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancerO A Khan, A D Blann, M J Payne, et al.
British Journal of Cancer|May 27, 2004
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancerP H Jones, K Christodoulos, N Dobbs, et al.
European Journal of Clinical Investigation|April 16, 1998
Autoantibodies directed against phospholipids or human beta 2-glycoprotein I in HIV-seropositive patients: relationship with endothelial activation and antimalonic dialdehyde antibodiesJ Constans, V Guérin, A Couchouron, et al.
Journal of the American Chemical Society|November 13, 2004
Ethylene tetramerization: a new route to produce 1-octene in exceptionally high selectivitiesAnnette Bollmann, Kevin Blann, John T Dixon, et al.
Thrombosis and Haemostasis|February 16, 2005
Circulating endothelial cells. Biomarker of vascular diseaseAndrew D Blann, Alexander Woywodt, Francesco Bertolini, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 20, 2013
The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational studyK Y Thong, T J McDonald, A T Hattersley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesisJ P Braybrooke, K J O'Byrne, D J Propper, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral CirculationJohn Lekakis, Pierre Abraham, Alberto Balbarini, et al.
Cancer|September 16, 2006
Arkansas Special Populations Access Network perception versus reality--cancer screening in primary care clinicsWilliam Rutledge, Regina Gibson, Eric Siegel, et al.
Pageof 42

Showing results (411-420 of 420) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 420 results.
Dalton Transactions (Cambridge, England : 2003)|March 10, 2021
Ethylene oligomerisation chromium catalysts with unsymmetrical PCNP ligandsKevin Blann, Annette Bollmann, Gavin M Brown, et al.
British Journal of Cancer|May 19, 2011
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancerO A Khan, A D Blann, M J Payne, et al.
British Journal of Cancer|May 27, 2004
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancerP H Jones, K Christodoulos, N Dobbs, et al.
European Journal of Clinical Investigation|April 16, 1998
Autoantibodies directed against phospholipids or human beta 2-glycoprotein I in HIV-seropositive patients: relationship with endothelial activation and antimalonic dialdehyde antibodiesJ Constans, V Guérin, A Couchouron, et al.
Journal of the American Chemical Society|November 13, 2004
Ethylene tetramerization: a new route to produce 1-octene in exceptionally high selectivitiesAnnette Bollmann, Kevin Blann, John T Dixon, et al.
Thrombosis and Haemostasis|February 16, 2005
Circulating endothelial cells. Biomarker of vascular diseaseAndrew D Blann, Alexander Woywodt, Francesco Bertolini, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 20, 2013
The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational studyK Y Thong, T J McDonald, A T Hattersley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesisJ P Braybrooke, K J O'Byrne, D J Propper, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral CirculationJohn Lekakis, Pierre Abraham, Alberto Balbarini, et al.
Cancer|September 16, 2006
Arkansas Special Populations Access Network perception versus reality--cancer screening in primary care clinicsWilliam Rutledge, Regina Gibson, Eric Siegel, et al.
Pageof 42